Tardive Dyskinesia

November 05, 2020

Learn about the results of the recent study on deutetrabenazine and the ways it is helping patients with tardive dyskinesia.

May 31, 2019

There are a few things that we all agree on, as reflected in a recent consensus statement.

May 30, 2019

Numbers don’t tell the whole story, but gaining a better sense of the frequency, risks, and impact on patients’ quality of life can help improve treatment efforts and enhance outcomes.

May 22, 2019

There are ways to prevent, manage, and treat TD, and this podcast will guide you through those steps from FDA-approved medications to off-label therapies.

May 13, 2019

Once thought untreatable, we now have two FDA-approved medications for TD and a handful of off-label options. More in this research update.

May 13, 2019

Tardive dyskinesia hits affected populations hard, especially older folks with poor support systems.

April 23, 2019

Recent studies and reviews report great progress in bringing TD under control.

April 17, 2019

Some dyskinesias improve with antipsychotic treatment, and these types are more common than thought. More in this podcast.

April 17, 2019

A prediction model may help identify treatment characteristics associated with TD among patients with psychiatric disorders taking antipsychotic medications.

April 01, 2019

This video will help clinicians detect tardive dyskinesia and movement disorders in patients taking antipsychotic drugs.